pipette
ESEspañol

High definition longitudinal spatial atlas of psoriasis reveals SPRR2F+ keratinocytes and distinct tissue-resolution trajectories under IL-17 and IL-23 inhibition

T. Sezin, N. Oktafina Prayitno, Y. Gupta, S. Mousavi, X. Tang, D. L. Bivona, H. Zirpel, S. Staender, D. A. De Luca, C. Papara, L. Pommerien, D. Thaci

PreprintClaims a big step

In the authors' words

How inflammation is established and resolved within tissues remains a fundamental question in human biology. Psoriasis is a chronic inflammatory skin disease driven by the IL-23/IL-17 pathway, with IL-17 pathway targeting biologics producing more rapid clinical improvement than IL-23 inhibitors. This difference raises the question of how IL-17 and IL-23 inhibition differentially remodel the cellular and transcriptional landscape of psoriatic skin during resolution. Here, we generated a longitudinal spatial atlas of plaque psoriasis using 2 micron high-definition spatial transcriptomics (HD-SPT), profiling 42 matched biopsies from 11 biologic treatment-naive patients before and during IL-17- or IL-23-targeted therapy. By integrating HD-SPT with a single-cell RNA-sequencing (sc-RNAseq) reference atlas, we resolved the cellular composition and spatial organization of psoriatic skin and mapped its remodeling during treatment. We identified a distinct cluster of SPRR2F+ keratinocytes (KCs) that was spatially restricted to the upper stratum granulosum at the transition to the stratum corneum and was strongly associated with inflamed psoriatic epidermis. SPRR2F+ KCs were enriched for antimicrobial and inflammatory barrier genes, including S100A8, S100A9, LCN2, IL36G, and PI3, and their abundance correlated with disease activity during treatment. In psoriasis patient-derived human epidermal KCs (P-HEK), SPRR2F knockdown attenuated inflammatory and antimicrobial transcriptional responses, supporting a functional role for SPRR2F in sustaining the inflammatory KC response in psoriasis. Longitudinal profiling further revealed distinct trajectories of tissue remodeling following IL-17 and IL-23 inhibition. Following IL-17 inhibition, SPRR2F+ KCs and their characteristic transcriptional signature resolved rapidly, whereas IL-23 inhibitors produced more gradual resolution of KC-centered transcriptional changes accompanied by broader immune and stromal remodeling. Together, these findings established the first HD-SPT atlas of a human skin disease and revealed distinct cellular and transcriptional trajectories of psoriatic skin during therapeutic resolution, identifying SPRR2F as a regulator of persistent KC inflammation.

Main resultThe abstract does not state a limitation.

In plain words AI summary

The researchers created a detailed map of psoriasis skin using high-definition spatial transcriptomics. They found a specific group of skin cells called SPRR2F+ keratinocytes that appear in inflamed areas. These cells contain genes linked to inflammation and antimicrobial defense. Blocking IL-17 removed these cells quickly, while blocking IL-23 caused slower, broader changes. The study suggests SPRR2F helps maintain inflammation in psoriasis skin cells.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Thursday, October 22. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.21.26365789